Sirisoft PCL
SET:SRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sirisoft PCL
SET:SRS
|
TH |
|
P
|
Pharol SGPS SA
ELI:PHR
|
PT |
|
Idorsia Ltd
SIX:IDIA
|
CH |
|
Roche Holding AG
F:RHO
|
CH |
|
Kunlun Tech Co Ltd
SZSE:300418
|
CN |
|
China Railway Signal & Communication Corp Ltd
SSE:688009
|
CN |
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
Archtis Ltd
ASX:AR9
|
AU |
|
V
|
Visa Inc
SGO:V
|
US |
Balance Sheet
Balance Sheet Decomposition
Sirisoft PCL
Sirisoft PCL
Balance Sheet
Sirisoft PCL
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
32
|
19
|
62
|
596
|
540
|
325
|
|
| Cash Equivalents |
32
|
19
|
62
|
596
|
540
|
325
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
200
|
202
|
|
| Total Receivables |
21
|
49
|
56
|
149
|
163
|
176
|
|
| Accounts Receivables |
21
|
49
|
56
|
149
|
163
|
176
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
11
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
47
|
92
|
117
|
201
|
237
|
|
| Total Current Assets |
64
|
115
|
210
|
862
|
1 104
|
940
|
|
| PP&E Net |
6
|
61
|
86
|
222
|
192
|
171
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
49
|
|
| Other Long-Term Assets |
8
|
14
|
16
|
50
|
87
|
99
|
|
| Total Assets |
78
N/A
|
189
+144%
|
311
+65%
|
1 134
+264%
|
1 384
+22%
|
1 260
-9%
|
|
| Liabilities | |||||||
| Accounts Payable |
20
|
19
|
65
|
115
|
195
|
158
|
|
| Accrued Liabilities |
8
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
6
|
10
|
23
|
25
|
36
|
|
| Other Current Liabilities |
2
|
69
|
104
|
123
|
245
|
235
|
|
| Total Current Liabilities |
30
|
99
|
178
|
261
|
464
|
428
|
|
| Long-Term Debt |
0
|
40
|
49
|
140
|
118
|
106
|
|
| Other Liabilities |
1
|
8
|
13
|
38
|
97
|
64
|
|
| Total Liabilities |
31
N/A
|
147
+373%
|
241
+64%
|
438
+82%
|
679
+55%
|
598
-12%
|
|
| Equity | |||||||
| Common Stock |
3
|
3
|
30
|
80
|
80
|
80
|
|
| Retained Earnings |
44
|
39
|
40
|
12
|
20
|
23
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
604
|
604
|
604
|
|
| Total Equity |
47
N/A
|
42
-9%
|
70
+66%
|
696
+889%
|
705
+1%
|
661
-6%
|
|
| Total Liabilities & Equity |
78
N/A
|
189
+144%
|
311
+65%
|
1 134
+264%
|
1 384
+22%
|
1 260
-9%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
160
|
160
|
160
|
160
|
160
|
160
|
|